We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Birincil immün yetersizliklerde, Mycobacterium Bovis ve mikobakterilerin sıklığı.
- Authors
Ulusoy, Ezgi; Karaca, Neslihan Edeer; Aksu, Güzide; Çavuşoğlu, Cengiz; Kütükçüler, Necil
- Abstract
Aim: Susceptibility to mycobacterial diseases is observed in some primary immunodeficiency diseases. In this study, we aimed to evaluate mycobacterial infections in primary immunodeficiency diseases. Material and Methods: Patients under follow-up by Ege University Pediatric Immunology Department for severe combined and combined immunodeficiencies, interleukin 12/ interferon gamma receptor deficiency, nuclear factor kappa-beta essential modulator deficiency and chronic granulomatosis disease were evaluated retrospectively in terms of the frequency and characteristics of mycobacterial infections using a questionnaire form for demographic properties, clinical features and laboratory tests. Results: A diagnosis of mycobacterial infection was made clinically in a total of 25 patients including five (11.3%) of 45 patients who had severe combined immune deficiency, 12 (52.3%) of 21 patients who had chronic granulomatous disease, four patients (100%) who had interferon gamma receptor 2 partical deficiency, two patients (100%) who had interleukin 12 receptor beta 1 deficiency and one patient (100%) who had nuclear factor kapa-beta essential modulator deficiency. Mycobacterium strain could be typed in 14 (33%) of these 25 patients including Mycobacterium bovis, Mycobacterium chelonea, Mycobacterium elephantis, Mycobacterium fortuitum, and Mycobacterium tuberculosis. All patients were treated with anti-tuberculosis therapy. Thirty-six percent of these 25 patients underwent hematopoietic stem cell transplantation. Eight patients (five before, three after transplantation) died. Conclusions: Non-tuberculosis mycobacteria including mainly Mycobacterium bovis were observed with a higher rate compared to Mycobacterium tuberculosis in primary immunodeficiencies, especially in those affecting the interleukin 12/interferon gamma pathway. Early diagnosis of primary immunodeficiencies with neonatal screening program and preventing administration of the Bacille Calmette-Guerin vaccine in these patients is important.
- Subjects
BCG vaccines; IMMUNOLOGICAL deficiency syndromes; INTERLEUKINS; MYCOBACTERIAL diseases; DNA-binding proteins; INTERFERON gamma release tests
- Publication
Türk Pediatri Arşivi, 2017, Vol 52, Issue 3, p138
- ISSN
1306-0015
- Publication type
Article
- DOI
10.5152/TurkPediatriArs.2017.5240